Walk into almost any pharmacy or grocery store and the supplement aisle now rivals the medication section in both length and ambition. Capsules promise sharper focus, fortified sleep, accelerated metabolism, and something vaguely described as “cellular renewal.” The labels are glossy, the claims are large, and the prices reflect neither of those things having much to do with proof. The global dietary supplement market was valued at roughly $167 billion in 2023, and analysts expect it to keep climbing. Understanding what you are actually buying — and what the regulatory framework does and does not guarantee — is not a niche concern. It is basic consumer literacy.

This is not a case for abandoning supplements wholesale. Some have genuine, well-replicated evidence for particular groups of people. Others are expensive placebo at best and potentially harmful at worst. The difference matters, and knowing how to find it is more useful than any single product recommendation.

How Supplements Are — and Are Not — Regulated

The single most important thing to understand about the supplement market in the United States is that supplements are regulated as a category of food, not as pharmaceuticals. The 1994 Dietary Supplement Health and Education Act (DSHEA) established this framework, and its consequences are profound. Unlike a prescription drug or even an over-the-counter medication, a dietary supplement does not have to demonstrate safety or efficacy before it reaches store shelves. The burden falls on the Food and Drug Administration to prove a product is unsafe after the fact — a considerably harder task.

Manufacturers are permitted to make what the FDA calls “structure/function claims” — statements such as “supports immune health” or “promotes healthy joints” — without clinical evidence, provided they carry a disclaimer noting that the FDA has not evaluated the claim. That small-print disclaimer appears on virtually every bottle in the aisle. It is not a mark of unusual modesty; it is legally required boilerplate. The FDA does prohibit manufacturers from claiming a supplement can treat, cure, or prevent a named disease, but the line between “supports cardiovascular health” and “treats heart disease” is not always policed vigorously, and the agency’s enforcement resources are finite.

The Federal Trade Commission, which oversees advertising, has pursued cases against companies making fraudulent health claims — particularly for weight-loss and memory-enhancement products — but the volume of misleading marketing far exceeds the pace of enforcement actions. The FTC’s own consumer guidance notes that “just because a product says it’s natural doesn’t mean it’s safe or effective.”

Third-Party Testing: The Practical Workaround

Because pre-market approval is not required, independent certification has emerged as a partial substitute. Organizations such as USP (the U.S. Pharmacopeia), NSF International, and ConsumerLab test supplements for label accuracy, contaminant levels, and manufacturing quality. A product bearing one of these seals has been verified to contain what it claims to contain, in the stated amounts, without dangerous adulterants. This does not mean it will produce the health outcome on the label — but it is a meaningful signal that the manufacturer is not cutting corners on basic quality control. When choosing between otherwise comparable products, a third-party seal is a reasonable tiebreaker.

Where the Evidence Is Genuinely Solid

Not everything in the supplement aisle is unfounded. A handful of nutrients have accumulated sufficient evidence to warrant targeted use in specific populations — with important caveats about who benefits and who likely does not.

Vitamin D is probably the most widely discussed. The NIH Office of Dietary Supplements notes that many Americans have insufficient levels, particularly those with limited sun exposure, darker skin, older adults, and people with certain fat-malabsorption conditions. There is good evidence that adequate vitamin D supports bone health and calcium absorption, and deficiency is associated with a range of negative outcomes. The leap from “deficiency is harmful” to “supplementing will improve health in people who are not deficient” is less supported, however. Large randomized trials, including the VITAL study published in The New England Journal of Medicine, found that vitamin D supplementation did not significantly reduce cancer incidence or cardiovascular events in adults without deficiency. The practical takeaway: if your clinician has confirmed low levels through a blood test, supplementation is reasonable. Taking high-dose vitamin D speculatively is a different proposition.

Vitamin B12 presents a clearer case for certain groups. B12 is found almost exclusively in animal products, so people following strict vegan or vegetarian diets face a genuine gap. Older adults also absorb it less efficiently as gastric acid production declines with age. Deficiency causes serious neurological and hematological problems, and supplementation for at-risk individuals is well-supported. For omnivores with normal absorption, a B12 supplement is unlikely to do anything beyond what diet already provides.

Omega-3 fatty acids (EPA and DHA, found in fish and algae) have a long and somewhat contested research history. Cochrane reviews of omega-3 supplementation have found modest benefits for cardiovascular outcomes in high-risk populations, though earlier enthusiasm for broad cardioprotective effects has been tempered by larger trials showing more limited results. Omega-3s remain among the more thoroughly studied supplements, and for people who eat little to no fatty fish, there is a reasonable nutritional rationale. The evidence for other headline claims — depression, cognitive decline, inflammation — is more mixed and should not be treated as settled.

Creatine monohydrate occupies a peculiar position: it is among the most extensively researched sports-nutrition supplements, with consistent evidence that it can modestly increase high-intensity exercise performance and support muscle mass gains when combined with resistance training. It is not a steroid and does not carry the risks of many “performance” products. Emerging research also explores potential cognitive benefits, particularly in older adults or those with dietary deficits. Creatine is an unusual case where the evidence base is genuinely robust for a narrow, specific purpose.

Where the Evidence Is Thin or Absent

The more interesting story, commercially speaking, is the large category of popular supplements for which robust clinical evidence does not exist — or exists and is unimpressive.

Multivitamins are the category most Americans purchase. Large observational and randomized studies, including the Physicians’ Health Study II, have found little evidence that daily multivitamin use reduces major disease risk in well-nourished adults. For people with genuine dietary gaps, they may fill deficiencies. For people eating a reasonably varied diet, the benefit is likely minimal, and some research suggests that high doses of certain fat-soluble vitamins (A, E, K) can cause harm.

Immune-boosting blends — typically combining zinc, vitamin C, elderberry, echinacea, and a supporting cast of botanicals — are perennial bestsellers. Some individual components have limited supporting evidence in very specific contexts (zinc lozenges may modestly reduce cold duration when taken at the onset of symptoms, per some Cochrane analyses), but the evidence for proprietary blends as marketed is generally absent. “Boosting” the immune system is not a coherent biological goal; the immune system is a complex, tightly regulated network, not a dial you can turn up.

Fat burners and metabolism supplements remain a category the FTC has repeatedly targeted for deceptive marketing. Ingredients such as garcinia cambogia, raspberry ketones, and green coffee extract have been the subject of infomercials and celebrity endorsements but have not demonstrated meaningful weight-loss effects in rigorous clinical trials. Some thermogenic stimulants carry cardiovascular risks at higher doses.

Collagen supplements are a more recent entrant. The biological plausibility argument — that consuming collagen peptides might support skin or joint collagen — is real but limited; most ingested protein is broken down into amino acids, not delivered intact to specific tissues. The clinical trial data is preliminary and largely funded by industry. It is not impossible that collagen supplements do something useful; the evidence is simply not at a level that justifies confident claims.

Reading a Label Without Being Misled

A few practical principles apply across the board. Proprietary blends — listed as a single total weight without individual ingredient amounts — prevent you from assessing whether any active ingredient is present at a dose that any study actually used. This is a meaningful red flag. Pixie-dusting is the practice of including a trendy ingredient at a dose far below what research suggests is active; the ingredient appears on the label, the marketing copy invokes it, and the dose does nothing.

  • Look for third-party certification (USP, NSF, ConsumerLab) as a basic quality signal.
  • Check whether the FDA disclaimer is present — its absence on a disease-treatment claim is itself a warning sign.
  • Search the NIH ODS fact sheets for the specific ingredient; they summarize the evidence plainly and are freely available.
  • Be skeptical of any product citing a single study, particularly if it was small, short, or funded by the manufacturer.
  • High prices are not a proxy for higher quality or better evidence.

A Word on Interactions and Individual Context

One underappreciated risk is interaction with prescribed medications. Vitamin K affects anticoagulants. St. John’s Wort is a potent inducer of liver enzymes and can reduce the effectiveness of drugs including antidepressants, antiretrovirals, and oral contraceptives. High-dose vitamin E may increase bleeding risk. The popular assumption that natural products are inherently safe ignores basic pharmacology: anything biologically active can interact with other biologically active things.

This is where the conversation with a clinician earns its place. The goal of this article is not to produce a shopping list or a blacklist but to build the kind of background that makes a conversation with a doctor or registered dietitian more productive. If you are considering a supplement for a specific reason, knowing what the evidence actually shows — and what questions to ask — is far more valuable than the back of a bottle.

The Bottom Line

The supplement industry occupies an unusual regulatory space: it sells products that look like medicine, make claims adjacent to medicine, but is required to prove almost none of it before taking your money. That does not mean nothing in the aisle works. It means the burden of inquiry falls on the consumer in a way it does not with prescription drugs. A small number of supplements have earned their place in the evidence base for specific people in specific circumstances. Most have not. The difference is knowable, and knowing it is worth more than any capsule.